Track topics on Twitter Track topics that are important to you
TC Biopharm has just received the largest award of its kind to develop allogeneic gamma-delta T cell therapies for various cancers. Based in Glasgow, TC Biopharm was just selected to receive €4M from Horizon 2020 for its “off-the-shelf” gamma-delta T cell program. ...
This awesome article Scottish Biotech gets €4M from Horizon 2020 for Off-the-Shelf Cell Therapy appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)NEXT ARTICLE